Stock Hot Tips

Reported by: Eric CRWE Newswire Middle East correspondent

Taiwan’s Acer Inc recently created an alliance with China’s Founder Technology to use the Founder’s PC related trademarks for seven years. As per the terms of the agreement Acer will pay $67.5 million for the license of China’s Founder Technology.

Per the agreement Acer will have access to Founder’s wide network which will allow Acer to enhance its marketing efforts while China’s Founder Technology will provide support for its PC manufacturing unit and manage Acer’s after sales service.

Acer currently is ranked as the third largest PC manufacturer in the world and with its latest alliance it has plans to become the 2nd largest PC brand in Asia. Acer also anticipates revenue of $2.5 billion in China as a result of its new collaboration with the Chinese Founder Technology.

According to Acer its subsidiaries generated almost 51 million Yuan for license rights of the Founder technology and paid another 69 million Yuan for customer and distribution resources. Acer and Founder will launch new products in October which are already highly anticipated.

Acer Incorporated deals in research, development, design and manufacturing of personal computers and laptops. The company’s major brands include Acer, Gateway, Packard Bell and eMachines. Its product portfolio includes desktop PCs, notebooks, servers, storage products, monitors, high definition televisions, projectors, liquid crystal display monitors and handheld devices.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

SHANGHAI, CHINA–(CRWENewswire - 08/11/10) - ARC China released the latest edition of its newsletter ARC China Weekly today. The publication includes a commentary from ARC China Founder Adam Roseman as well as articles covering topics of general interest with a focus on consumer and retail, alternative energy, recent investment transactions in China’s current news, and transactions in the Middle East, Europe, and the United States.

Roseman’s foreword focuses on China’s uninterrupted economic ascent as the country is set to overtake Japan as the second largest economy in the world in a resurgence that is changing everything from the global balance of military and financial power to how cars are designed. China is moving up the food chain faster than anyone thought possible, and even beginning to challenge Japan at the very core of its economy: high-end manufacturing.

China’s GDP in 2009 was $4.98 trillion and Japan’s was $5.07 trillion. In 2010, China’s GDP was $1.335 trillion for the April-June quarter — a period for which Tokyo has yet to report. China is growing at 10% a year while Japan’s expansion this year is forecast at no more than 3%.

The continuous rise of China’s economy has seen the country overtake Britain and France in 2005 and then Germany in 2007 and is gradually translating into clout on the world stage. China is a leading member of the G20, which since the 2008 financial crisis has become the world’s premier economic policy-setting forum. China’s ascent to become the world’s second largest economy may only be overshadowed by the global influence that it has already attained.

The newsletter can be found online at http://www.arcchina.cn/this-week-in-china/volume-73/.

About ARC China

ARC China is an investment firm focused on investments in entrepreneur-owned small and medium sized enterprises located in Tier II and Tier III Chinese cities. We seek to create value for our investors and companies we invest in by applying our professional experience and relationships to help companies upgrade their management teams, technology, systems, and business processes. Our team of experienced investment professionals and in-house due diligence analysts deploy a proven and unique on-the-ground activist investment strategy of making value-oriented highly involved, exit-driven equity investments in a diversified portfolio of domestic consumption-focused high-growth Chinese businesses. We also provide various financial advisory services, for both inbound and outbound China transactions. For more information, please visit http://www.arcchina.cn.
Contact:

Contact:
Adam Roseman
ARC China
182 Chang Shu Road
Xu Hui District
Shanghai 200031, P.R. China
Email: Email Contact

Disclaimer:
CRWEnewswire is not liable for the contents of this news, as well as not being liable for any errors or delays in the content, or for any actions taken in reliance thereon. The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of Crown Equity Holdings or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company mentioned or referred to in the article.

By Hassan MohammadZaman Middle East correspondent for crwenewswire.com

In order to resolve the increasing pollution problem in the country, Sen. Juan Miguel Zubiri prepared a bill on Wednesday and made an Environmental Protection Agency (EPA)

The main objective of EPA is to do research, set the standards, monitor and implement by focusing on air pollution, water hazards, solid waste disposal, radiation and pesticides.

According to Senate Majority Leader, Department of Environment and Natural Resources has a task to execute government’s environmental laws and policies.

To take charge of observing and imposing environmental laws at the regional level, away from the chairman, other EPA officers will be regional executive directors to fulfill the responsibility.

The functions and tasks of the proposed EPA include establishment and enforcement of environmental protection standards which are in favor of the national environmental purposes and targets, recommend imposing laws for environmental protection, propagate laws and regulations consistent with the law administering the examination, protection, growth, taking out, disposition, use and other actions that may cause the diminution and dilapidation of natural resources.

Moreover it takes on investigation, judgment, arrangement and record of the country’s natural resources through technology. It will supervise and administer natural resources; it will propagate regulations related the control of water, air and land pollution.

Disclaimer:
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of Crown Equity Holdings or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company mentioned or referred to in the article.

Penwest Pharmaceuticals Co.(NasdaqGM: PPCO)

Last: $3.49

Change: +$0.71 (+25.54%)

Volume: 1,539,143

http://www.penw.com

About:

Penwest Pharmaceuticals Co., a drug development company, focuses on identifying and developing products that address unmet medical needs, primarily for disorders of the nervous system. Its proprietary drug delivery technologies include TIMERx, a controlled-release technology; Geminex, a technology enabling drug release at two different rates; SyncroDose, a technology enabling controlled release at the appropriate site in the body; and GastroDose system, a technology enabling drug delivery to the upper gastrointestinal tract. The company offers Opana ER, an oral extended release opioid analgesic for patients with moderate to severe pain requiring continuous opioid treatment using its TIMERx drug delivery technology; and Nifedipine XL, a generic version of Procardia XL, which is used for the treatment of hypertension and angina based on its TIMERx technology. Its products under development include Nalbuphine ER, a Phase IIa clinical trail completed product for the treatment of pain; and A0001, a Phase IIa clinical trail product for the treatment of diseases related to the inherited mitochondrial respiratory chain diseases. Penwest Pharmaceuticals Co. has strategic, collaborative, drug development, and licensing agreements with various companies, including Endo Pharmaceuticals Inc.; Edison Pharmaceuticals, Inc.; Mylan Pharmaceuticals Inc.; Otsuka Pharmaceuticals Co.; and Alvogen, Inc. The company was founded in 1991 and is based Patterson, New York..

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations.

StockHotTips.com Hot Stock News & Alerts!

******************************************************************

Adeona Pharmaceuticals, Inc. (AMEX: AEN)

AEN announced positive results of Part 1 of its CopperProof-2 clinical study of Zinthionein ZC (zinc cysteine) in Alzheimer’s disease and mild cognitive impairment.

About Adeona Pharmaceuticals, Inc.

Adeona Pharmaceuticals, Inc. operates as a pharmaceutical company that develops medicines for central nervous systems and autoimmune diseases.

Visit Adeona Pharmaceuticals, Inc. (AEN) for more information at http://www.adeonapharma.com

****************************

SIRIUS XM Radio Inc. (NasdaqGS: SIRI)

SIRI stemmed falling subscriber numbers during the first quarter, the satellite radio broadcaster said Wednesday, and company shares jumped 7 percent before the market opened.

About SIRIUS XM Radio Inc.

Sirius XM Radio Inc. provides satellite radio services in the United States and Canada.

Visit SIRIUS XM Radio Inc. (SIRI) for more information at http://www.siriusradio.com

*****************************

Crown Equity Holdings, Inc. (OTCBB: CRWE)

CRWE has expanded its internet footprint internationally to include the following 20 countries; Argentina, Australia, Brazil, Canada, China, France, French-Canadian, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK. CRWE has a huge internet footprint with two separate IT divisions (engineers and programmers) that are constantly involved in the R&D of IT and network technology to improve and assist in their advertising and marketing endeavors besides managing their in house server infrastructure of over 2000 websites, blogs and thousands of third party blogs and websites.

CRWE’s revenue for the year totaled $659,907 compared to $29,190 during 2008. Net income after taxes in 2009 was $93,927 compared to a net loss of $316,131 in 2008 with working capital increasing by $542,341 in 2009.

About Crown Equity Holdings, Inc.

Crown Equity Holdings, Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.

Visit Crown Equity Holdings, Inc. (CRWE.OB) for more information at www.crownequityholdings.com

******************************************************************

***********Advertisement***********

Be sure to Check Out StockHotTips.ning.com

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

** The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.